Member access

4-Traders Homepage  >  Shares  >  Amex  >  ImmunoCellular Therapeutics Ltd    IMUC   US4525361055

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Amex
11/18/2014 11/19/2014 11/20/2014 11/21/2014 11/24/2014 Date
0.6199(c) 0.63(c) 0.65(c) 0.6363(c) 0.6061 Last
325 603 289 727 236 286 146 047 198 537 Volume
-0.02% +1.63% +3.17% -2.11% -4.75% Change
More quotes
Company
ImmunoCellular Therapeutics Ltd. is a clinical-stage biotechnology company, which focuses on developing immune-based therapies for the treatment of brain and other cancers.Its cell-based vaccine technologies are primary platform technologies and commercial prospects will be heavily dependent on the... 
More about the company
Chart IMMUNOCELLULAR THERAPEUTIC
Duration : Period :
ImmunoCellular Therapeutic Technical Analysis Chart | IMUC | US4525361055 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 -
EBIT 2014 -10,5 M
Net income 2014 -10,1 M
Debt 2014 -
Yield 2014 -
Sales 2015 -
EBIT 2015 -16,7 M
Net income 2015 -16,6 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 0
Capi. / Sales 2015 0
Capitalization 39,9 M
More Financials
Latest news on IMMUNOCELLULAR THERAPEUTIC
5d ago IMMUNOCELLULAR THERAPEUTICS : Announces Third Quarter 2014 Financial Results
11/14 IMMUNOCELLULAR THERAPEUTICS : Regulation FD Disclosure, Other Events, Financial ..
11/14 IMMUNOCELLULAR THERAPEUTICS : Presents Updated ICT-107 Phase II Data at the Soci..
11/11 IMMUNOCELLULAR THERAPEUTICS : Announces Third Quarter 2014 Financial Results
11/10 IMMUNOCELLULAR THERAPEUTICS : Management's Discussion and Analysis of Financial ..
11/10 IMMUNOCELLULAR THERAPEUTICS : Results of Operations and Financial Condition (for..
11/10 IMMUNOCELLULAR THERAPEUTICS : Announces Third Quarter 2014 Financial Results
10/03 IMMUNOCELLULAR THERAPEUTICS : to Present at Livingston Securities Conference on ..
10/03 IMMUNOCELLULAR THERAPEUTICS : Expands Cancer Immunotherapy Platform with Antigen..
09/26 IMMUNOCELLULAR THERAPEUTICS : to Present at Livingston Securities Conference on ..
09/24 IMMUNOCELLULAR THERAPEUTICS : Receives Positive Regulatory Feedback on ICT-107 S..
09/24 IMMUNOCELLULAR THERAPEUTICS : Expands Cancer Immunotherapy Platform with Antigen..
More news


Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF